SARA HAHN: Open Payments
NPI 1205202892 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 30 payments from 8 companies in 2025. Trend: 2023 $683 · 2024 $427 · 2025 $655
Food & beverage: $637Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $228 |
| GENZYME CORPORATION | 1 | $128 |
| Insmed, Inc. | 7 | $122 |
| Amgen Inc. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Verona Pharma, Inc. | 1 | $43 |
| Viatris Specialty LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: TRELEGY ELLIPTA, DUPIXENT, Arikayce, TEZSPIRE, Ohtuvayre, BREZTRI, YUPELRI, Brinsupri.
Industry payments across IN — which companies pay providers there.
